Literature DB >> 23136308

Steroid diffusion into the navicular bursa occurs in horses affected by palmar foot pain.

J M Manfredi1, M Boyce, E D Malone, C Anderson, L B Anderson, T N Trumble.   

Abstract

Palmar foot pain is frequently treated by steroid injections into the distal interphalangeal joint (DIPJ) in the anticipation that the steroid will diffuse to the navicular bursa and palmar foot structures. The object of this study was to determine if triamcinolone acetonide (TA) would in fact be able to locally diffuse from the DIPJ into the navicular bursa in horses affected by palmar foot pain. Both forelimb DIPJs (nine horses) were injected with 10 mg of TA. Navicular bursa fluid samples, both forelimb and one hind limb (systemic control), were analysed for TA with high-performance liquid chromatography/tandem mass spectrometry (HPLC-MS/MS) six hours later. Foot radiographs were graded (0-4) on severity of changes. Forelimb navicular bursa TA concentrations (mean±sd log(10), 3.20±0.56) were significantly higher than systemic control concentrations (mean±sd log(10), 1.89±0.3) (P<0.0001). Horses with a radiographic grade of >2 were four times as likely to have TA log(10) concentrations less than 3.2 (158.49 ng/ml). TA locally diffused from the DIPJ into the navicular bursa in horses affected by palmar foot pain; TA concentrations decreased as radiographic severity increased.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23136308     DOI: 10.1136/vr.101075

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  1 in total

1.  Mechanical nociceptive assessment of the equine hoof after navicular bursa anesthetic infiltration validated by bursography.

Authors:  Letícia de Oliveira Cota; Bruno Dondoni Malacarne; Lucas Antunes Dias; Antônio Catunda Pinho Neto; Maria Luiza Arruda Kneipp; Marina Alcântara Cavalcante; Marina de Souza Luz da Cunha; Cahuê Francisco Rosa Paz; Armando de Mattos Carvalho; Rafael Resende Faleiros; Andressa Batista da Silveira Xavier
Journal:  PLoS One       Date:  2022-06-07       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.